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Key Points: 
• Accurate identification of stroke patients at risk of falling is important for 
planning rehabilitation services on discharge 
• Two previously derived risk-prediction models for recurrent falls post-stroke 
have performed poorly in this validation study 
• A further large prospective cohort study is required to derive a useful falls-risk 
prediction model for this population 
• Future derivation studies should conduct internal validation and adhere to 
TRIPOD guidelines to facilitate external validation 
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Abstract 
 
Background: Several multivariable models have been derived to predict post-stroke 
falls. These require validation before integration into clinical practice. The aim of this 
study was to externally validate two prediction models for recurrent falls in the first 
year post-stroke using an Irish prospective cohort study. 
Methodology: Stroke patients with planned home-discharges from five hospitals 
were recruited. Falls were recorded with monthly diaries and interviews six and 12 
months post-discharge. Predictors for falls included in two risk-prediction models 
were assessed at discharge. Participants were classified into risk-groups using these 
models. Model 1, incorporating inpatient falls-history and balance, had a six-month 
outcome. Model 2, incorporating inpatient near-falls history and upper limb function, 
had a twelve-month outcome. Measures of calibration, discrimination (area under the 
curve (AUC)) and clinical utility (sensitivity/ specificity) were calculated. 
Results: 128 participants (mean age=68.6 years, SD=13.3) were recruited. The fall 
status of 117 and 110 participants was available at six and 12 months respectively. 
Seventeen and 28 participants experienced recurrent falls by these respective time-
points. Model 1 achieved an AUC=0.56 (95% CI 0.46–0.67), sensitivity=18.8% and 
specificity=93.6%. Model 2 achieved AUC=0.55 (95% CI 0.44–0.66), 
sensitivity=51.9% and specificity=58.7%. Model 1 showed no significant difference 
between predicted and observed events (Risk Ratio (RR)=0.87, 95% CI 0.16–4.62). 
In contrast, model 2 significantly over-predicted fall events in the validation cohort 
(RR=1.61, 95% CI 1.04–2.48). 
Conclusions: Both models showed poor discrimination for predicting recurrent falls. 
A further large prospective cohort study would be required to derive a clinically-
useful falls-risk prediction model for a similar population.   
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Introduction  
Stroke survivors fall at almost twice the rate of healthy peers with 5% sustaining 
serious fall-related injuries [1,2]. Falls are associated with slower stroke recovery and 
poorer psychological outcomes [3]. Accurate identification of those at risk is therefore 
important. Prognostic risk-prediction models, combining two or more variables, are 
developed to estimate an individual’s risk in order to facilitate clinical decision-
making [4]. Before widespread implementation, risk-prediction models should 
undergo three development stages: (i) Derivation: identification of prognostic factors 
to develop the model; (ii) Validation: testing of the model in a similar population 
(internal validation) and/or in a different population (external validation) (iii) Impact 
analysis: evaluation of the effect on patient outcomes, clinician behaviour or costs 
[5]. A recent systematic review summarised falls-prediction models derived within the 
first year after stroke [6]. Five studies derived nine models to predict falls in 
community-dwellers [7-11]. Three of these studies reported sufficient information to 
allow for model validation [9-11]. Two studies predicted recurrent falls, an outcome 
recommended by a consensus group for research on falls-prevention among older 
adults [9,11,12]. The third study included single falls in the outcome [10]. 
 
Mackintosh and colleagues [9] developed two prediction models for recurrent falls at 
six-months post-discharge, combining an impaired balance measure (either Berg 
Balance Scale score (BBS) <49 or Step Test score <7) and inpatient falls-history. 
Both models achieved sensitivity and specificity values >80%, but this should be 
interpreted with caution due to the small sample size (n=55 participants, n=12 
events) [9]. Ashburn and colleagues [11] also derived two models for recurrent falls 
but with a 12-month follow-up period. Their model combining six variables, achieved 
an area under the receiver operating characteristic (ROC) curve (AUC) of 0.71, and 
sensitivity and specificity of 64% and 69% respectively, suggesting moderate 
performance [4]. Their second model, combining upper limb function and inpatient 
“near-fall” history achieved similar performance [11]. Neither group conducted 
internal validation of their models but both acknowledged the need for external 
validation before clinical-practice recommendations could be made [4,9,11].  
 
The aim of this study was to externally validate two previously derived risk-prediction 
models for recurrent falls in the first year post-stroke in a consecutive sample of 
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recently discharged community-dwelling stroke survivors. 
 
Methodology  
This validation study was designed as part of the Falls Related EvEnts after StrokE 
(FREESE) prospective cohort study. Methods are reported according to the TRIPOD 
(Transparent Reporting of a multivariable prediction model for Individual Prognosis 
Or Diagnosis) guidelines [4]. Adult patients (aged >18 years) with a diagnosis of 
acute stroke and a planned discharge to home were consecutively recruited between 
November 2013 and August 2014 from five large, acute university teaching hospitals 
in Ireland. Acute stroke diagnoses included cerebral ischaemic infarction, ischaemic 
infarction with haemorrhagic transformation and intracerebral haemorrhages. Those 
discharged to a nursing home or unable to provide informed consent due to cognitive 
or severe receptive language deficits were excluded. Ethical approval was received 
from Research Ethics Committees at each hospital. Written informed consent was 
obtained from all participants. 
 
The outcome of interest was recurrent falls (>1 fall) over the follow-up period. A fall 
was defined as ‘‘an unexpected event in which the participants come to rest on the 
ground, floor, or lower level’’ excluding violent blows or seizures [9,12]. International 
recommendations for falls-ascertainment were followed [12]. Falls were recorded 
using daily diaries with monthly return. Reminder phone calls were made if 
necessary. Telephone or face-to-face interviews based on a falls-schedule used by 
Ashburn et al [11] were conducted to rectify missing data and to ascertain falls 
circumstances at six and 12 months post-discharge. 
 
One model with a six-month and one model with a 12-month follow-up period were 
chosen for validation. Of the two models derived by Mackintosh et al [9], the model 
including the BBS was chosen as this measure is commonly included in post-stroke 
studies investigating falls [6]. The model derived by Ashburn et al [11] combining two 
predictors was selected, as their study, with 48 events, was underpowered for the 
derivation of their six-item model  [6,13].  
 
The four predictors included in the two risk-prediction models were assessed in the 
validation cohort at baseline. The definitions of balance, inpatient falls and inpatient 
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near-falls were identical in the validation and derivation cohorts [9,11]. A 
physiotherapist assessed participants using the BBS (0-56 points) in the hospital or 
rehabilitation setting within a week pre-discharge [14]. As soon as possible post-
discharge, a researcher not involved in physical assessments telephoned 
participants and asked them to recall any falls or near-falls experienced in hospital. A 
near-fall was defined as “an occasion on which an individual felt that they were about 
to fall, but did not actually fall” [11]. The research physiotherapist remained blind to 
inpatient falls and near-falls history.  
 
The validation and derivation studies used different definitions of upper limb function. 
Ashburn et al [11] assessed upper limb function using the Rivermead Motor 
Assessment, which ranges from 0-15 points [15]. The validation study used the 
Motor Assessment Scale Upper Limb scale (MAS-UL), a similar measure commonly 
used in the Irish setting [16-17], which ranges from 0-18 points. A comparison of 
RMA and MAS-UL components was conducted and the validation cohort upper limb 
score was ‘re-weighted’ to a maximum of 15 points. See Appendix Table I for further 
details. 
 
Statistical analysis  
Participants with complete outcome data at the time-point of interest were included in 
the validation analysis and classified into risk-groups based on each model. 
Measures of calibration, discrimination and clinical utility were calculated. 
 
Mackintosh et al presented the following model: high-risk if BBS score <49/56 and 
an inpatient falls-history [9]. Therefore, participants in the validation cohort with both 
risk factors were classified as "high-risk" of recurrent falling and the remaining 
participants as "low-risk". This will be referred to as the "six-month model”. Ashburn 
et al [11] presented the following predictive score based on a logistic regression 
model: 0.293 + 1.29 (if inpatient near-fall) - (0.094)(Upper limb score). This value 
was calculated in the validation cohort using the re-weighted MAS-UL score. 
Participants of the validation cohort were categorised as "high-risk" or "low-risk" of 
recurrent falling based on the cut-off score of -0.4114 provided by Ashburn et al [11]. 
This will be referred to as the "12-month model". 
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Calibration, the agreement between predicted and observed outcomes, was 
assessed using a method described by Dimitrov et al [18,19]. The predicted number 
of events in the validation cohort were calculated using outcome frequencies across 
risk-groups in the derivation studies [19]. Estimates of “predicted: observed” risk 
ratios (RRs) were calculated with 95% confidence intervals (CIs), using a Mantel-
Haenszel random-effects analysis [20]. Discrimination, a model's ability to 
differentiate between individuals with and without the event, was quantified using the 
area under the ROC curve statistic (AUC). An AUC of 0.5 represents chance, 0.7–
0.9 represents moderate discrimination and 1.0 represents perfect discrimination [4]. 
ROC curves for both binary models were plotted with single operating points [21]. 
Sensitivity and specificity were calculated to assess clinical utility of the models. 
 
Missing values for each predictor were tabulated. Multiple imputations were 
conducted for missing values as a sensitivity analysis [4]. Data were analysed using 
Stata (version 13.1, StataCorp) and Review Manager (version 5.3, Cochrane 
Collaboration). 
 
Results  
A total of 128 participants were assessed at baseline in the validation cohort. 
Participants had a mean age of 68.6 years (SD=13.3 years) and a median length of 
stay of 14 days (IQR 7–38 days). The fall status of 117 and 110 participants was 
available at the six-month and 12-month follow-up time-points respectively. By six 
months 30 participants (25.6%) had fallen post-discharge, 17 repeatedly (14.5%). By 
12 months 49 participants (44.5%) had fallen, 28 repeatedly (25.5%). Appendix 
Figure I shows a flow diagram of participants through recruitment and follow-up. 
Table 1 shows a comparison between the validation cohort and both derivation 
cohorts [9,11]. Appendix Table II shows additional clinical characteristics of the 
validation cohort. Complete-case analyses, including 110 and 102 participants for 
the six and 12-month models respectively are presented below. 
 
Performance of the six-month model in validation cohort 
Eleven recurrent fallers were predicted and 16 were observed in the validation cohort 
at six months [9]. Figure 1a presents a breakdown across risk-groups. No statistically 
significant difference was found between observed and predicted events for the six-
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month model (RR=0.87, 95% CI 0.16–4.62). Appendix Figure II shows the forest plot 
of this analysis, stratified by risk-group. The six-month model showed poor 
discrimination in the validation cohort (AUC= 0.56, 95% CI 0.46–0.67). Figure 1b 
shows the non-parametric ROC curve. The model achieved high specificity (93.6%, 
95% CI 86.6–97.6) but low sensitivity (18.8%, 95% CI 4.1–45.6).  
 
Performance of the 12-month model in validation cohort 
Forty-three recurrent fallers were predicted and 27 were observed in the validation 
cohort at 12 months [11]. Figure 2a presents a breakdown across risk-groups. A 
statistically significant difference was found between the predicted and observed 
number of recurrent fallers for the 12-month model (RR=1.61, 95% CI 1.04–2.48). 
Appendix Figure III shows the forest plot of the analysis, stratified by risk-group. 
The 12-month model showed poor discrimination in the validation cohort (AUC=0.55, 
95% CI 0.44–0.66). Figure 2b shows the non-parametric ROC curve. The model 
shows both low sensitivity (51.9%, 95% CI 31.9–71.3) and specificity (58.7%, 95% 
CI 46.7–69.9%). 
 
There were very few missing values in this study (Table 1). Multiple imputation of 
missing values did not alter the overall results. 
 
Discussion  
This study attempted to externally validate two risk-prediction models for recurrent 
falls after stroke. Both models poorly discriminated between those with and without 
recurrent falls and also demonstrated low estimates of sensitivity, implying that they 
are unsuitable for accurately ruling out fall events. Additionally, the 12-month model 
showed statistically significant differences between predicted and observed 
outcomes. 
 
In the original derivation study the six-month model achieved high sensitivity and 
specificity [9]. This performance was not replicated in the current study. Firstly, 
possibly due to longer inpatient stay duration, the derivation cohort had four times 
the inpatient falls incidence of the validation cohort [9]. They also had a higher falls 
(45% versus 26%) and recurrent fall rate (22% versus 15%) at six months [9]. 
Secondly, the derivation study had a small sample size (12 events). The original 
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reported adjusted odds ratios (OR) for the model predictors showed wide 95% 
confidence intervals (fall in hospital OR= 20.5 (2.2-190.6)) and no internal validation 
techniques were performed. [9] The model was likely over-fitted to the derivation 
sample, leading to optimistic performance measures [4].  
 
The 12-month model showed an AUC of 0.69 in the derivation cohort [11], but poorer 
performance in the current validation cohort. This may be due to a lack of internal 
validation or differences in duration since stroke, near-fall incidence and upper limb 
function definition between the validation and derivation cohorts [4,11]. The 
difference in duration since stroke may be partly accounted for by recent changes to 
stroke care, including improved diagnosis, hyper-acute treatment, and earlier 
discharge [22]. Despite a shorter length of stay, our participants reported more near-
falls [11]. Participants in the two studies may have interpreted the meaning of "near-
fall" differently [23]. Furthermore, although the definition of upper limb function varied 
across studies a conservative method was used for re-weighting [11,15,17]. Despite 
similar recruitment and falls-ascertainment methods, Ashburn et al found a higher 
falls rate (55% versus 45%) and recurrent falls rate (42% versus 26%) than the 
validation study at 12 months [11].  
 
Prediction model performance can sometimes be improved by re-calibration to the 
new setting, re-estimation of coefficients or including additional predictors [13]. This 
was not appropriate in the current study. Firstly, Mackintosh and colleagues 
presented a dichotomous score rather than the full regression model [9]. Secondly, 
both models showed poor discrimination. Simple re-calibration would not have 
improved performance [13]. Finally, the original derivation studies had several 
clinical and statistical limitations, including predictor definitions. Mackintosh et al 
dichotomised the BBS score prior to modelling [9], thus limiting the ability to 
investigate any non-linear relationship between balance and falls [4,24]. A “near-fall” 
as defined in the 12-month model derivation study may have been ambiguous for 
people early post-stroke [23]. Continuous patient-reported assessments including the 
falls-efficacy scale may have more reliability and power during statistical modelling 
[4,25]. 
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Limitations 
This study has some limitations. The sample size was relatively small with 17 and 28 
events at six and 12 months respectively. While a single ‘simulation study’ has 
recommended that 100 outcome events and 100 ‘non-events’ are required for 
external validation, this principle has not been widely accepted [18,26]. Although it 
was not the original study aim, the number of outcome events would have prevented 
major model updating using the validation dataset, should this have been deemed 
appropriate [13].  
 
Resource limitations, including the number of assessors available, did not allow for 
full blinding of predictor-predictor and predictor-outcome assessment, resulting in 
possible sources of bias [4]. Blinding the physiotherapist to fall-related events was 
prioritised to avoid biasing on-going recruitment and physical assessments that can 
require subjective judgement [4]. Despite the prospective study design, there was a 
small amount of missing predictor data (less than 8% of participants). The treatment 
of missing values has been reported for transparency [4], and multiple imputation did 
not significantly alter the results. 
 
Future implications 
The models in this study are not suitable for impact analysis or clinical use. A large 
derivation study would be required to develop a falls-risk prediction model for this 
population with acceptable performance and generalisability. As falls are complex, 
risk-prediction models should include more predictors [27]. The most common falls 
predictors entered into multi-variable models in post-stroke cohort studies are 
measures of neglect, gait speed, cognition, depression, falls-efficacy, the BBS and 
the Timed Up and Go test [6]. A derivation study with seven candidate predictors 
would require 70 events (an estimated sample size of approximately 400 participants 
based on the current study) for sufficient power to predict recurrent fall events [13]. 
Researchers should model variables continuously where possible, conduct internal 
validation and adhere to TRIPOD reporting guidelines to facilitate the external model 
validation [4, 13, 24]. Specifically, the full final regression formula needs to be 
presented to allow for re-calibration to other settings [4]. 
 
Our study indicates that it is not currently possible to accurately predict recurrent 
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community falls after stroke at the point of discharge. Ashburn and colleagues [11] 
recommended that in the absence of conclusive evidence, all people with stroke 
returning home should be considered at risk of falls. This is supported by the current 
study and the up-to-date NICE guidelines for falls-prevention in older adults [28]. 
Deeming all stroke survivors to be at risk would have implications for service 
provision. For this reason and because multi-factorial post-stroke falls-prevention 
interventions have not yet shown effectiveness [29], further research is required to 
identify falls-management strategies applicable to a broad post-stroke population. 
This could include the design of a complex intervention informed by qualitative 
research with survivors of stroke [30]. 
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Table 1. Comparison between derivation and validation cohorts 
 
 Six-month model 
derivation cohort 
(Mackintosh et al 2006) 
Twelve-month model 
derivation cohort 
(Ashburn et al 2008) 
Validation cohort  
 N=55 N=115 N=117 at six months 
N=110 at 12 months 
Mean age in years (SD) 68.1 (12.8) 70.2 (N/R) 68.5 (13.5)  
Male gender 45%  62%  62%  
Mean no. of months from stroke onset at baseline  2.3 (SD 1.6) 2.6 (range 0.3-11) 0.8 (SD 1.2, range 0.1-5.4)) 
Previous stroke (%) 20.0% 16.5% 14.5% 
BBS<49 (%) 47.3% N/A 47.8% (m=4)* 
Fall in hospital (%) 41.8% N/A 11.3% (m=7)* 
Near-fall in hospital (%) N/A 26.1% 43.0% (m=3)# 
Upper limb function assessment measure  N/A RMA mean: 10.5 Adjusted MAS-UL mean: 
12.8 SD 2.6 (m=5)# 
No. of recurrent fallers at 6 months (% of sample) 12 (21.8%) N/A 17 (14.5%) 
No. of recurrent fallers at 12 months  (% of sample) N/A 48 (41.7%) 28 (25.2%) 
*m= number of participants missing data for predictor out of 117 
#m= number of participants missing data for predictor out of 110 
N/R=Not reported 
N/A=Not applicable 
BBS=Berg Balance Scale, RMA=Rivermead Motor Assessment, MAS=Motor Assessment Scale 
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Figure 1. Performance of the six-month model in validation cohort 
 
 
 
 
Figure 2. Performance of the 12-month model in validation cohort 
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APPENDICES 
 
Validation of two risk-prediction models for recurrent falls in the first 
year after stroke: a prospective cohort study 
 
 
Appendix Table I. Re-weighting method for upper limb score in validation cohort 
MAS section RMA Comparison Re-weighting of MAS Score 
in validation cohort 
MAS Upper Arm  
(out of 6 points) 
RMA awards a maximum of 
4 points for identical items 
Multiply score by 0.6666 
(i.e. 4/6) 
MAS Hand Movements 
(out of 6 points) 
RMA awards a maximum of 
5 points for 3 identical items 
and 2 similar items 
Multiply score by 0.8333 
(i.e. 5/6) 
MAS Advanced Hand 
Activities  
(out of 6 points) 
RMA awards a maximum of 
6 points for 4 similar items 
and 2 other advanced hand 
activities 
Keep score same  
(i.e. 6/6) 
Total=18 Total=15 Total=15 
MAS= Motor Assessment Scale 
RMA= Rivermead Motor Assessment 
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Appendix Table II. Stroke details and clinical characteristics of validation 
cohort on admission	and on discharge 
 
	 	 N (%) 
Previous stroke history First stroke 106 (82.8) 
 History of previous stroke 22 (17.2) 
Bamford Classification TACI 3 (2.3) 
 PACI 54 (42.2) 
 LACI 20 (15.6) 
 POCI 27 (21.1) 
 Haemorrhage 12 (9.4) 
 TIA (as final diagnosis) 5 (3.9) 
 Other/ multiple sites 7 (5.5) 
Side of stroke Right Cerebrum 49 (38.6) 
 Left Cerebrum 46 (36.2) 
 Cerebellar/ Brainstem/ 
Bilateral/ other 
32 (25.2) 
Initial stroke severity NIHSS=0 8 (6.6) 
 Mild (NIHSS 1-4) 68 (56.2) 
 Moderate (NIHSS 5-15) 41 (33.9) 
 Severe (NIHSS >15) 4 (3.3) 
Thrombolised Yes 15 (11.8) 
 No (ischaemic) 100 (78.8) 
 Haemorragic stroke 12 (9.4) 
Functional Co-morbidity Index 0 conditions 36 (28.1) 
 1 condition 34 (26.6) 
 2 conditions 31 (24.2) 
 3+ conditions 27 (21.1) 
Fall history Fall in year prior to stroke  22 (20.2) 
 History of fracture  13 (10.2) 
Independence in ADLs  on discharge Independent (Barthel=100) 55 (45.8) 
 Barthel 90-95 30 (25.0) 
 Barthel 80-85 27 (22.5) 
 Barthel 65-75 8 (6.7) 
TACI: Total Anterior Circulation Infarct  
PACI: Partial Anterior Circulation Infarct  
LACI: Lacunar Infarct 
POCI: Posterior Circulation Infarct  
NIHSS: National Institutes of Health Stroke Scale 
TIA: Transient Ischaemic Attack 
ADLs: Activities of Daily Living 
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Appendix Figure I. Flow diagram of recruitment and follow-up in 
validation cohort 
Assessed 
(n=128)
Falls status available at
6-months (n=117)
Falls status available at 
12-months  (n=110)
Six-month dropout (n=11)
4 Died
5 Unable to contact
1 In hospital
1 Withdrew from ongoing 
participation
12-month dropout (n=7)
3 Medically unwell (non 
fall-related)
3 Withdrew from ongoing 
participation
1 Died
Referred for screening 
(n=322)
Male n=191, Female n=131
Eligible 
(n=270)
Consented
(n=149)
Not Eligible (n=52)
31 Cognitive deficits
7 Receptive aphasia
14 Other exclusion criteria
Eligible but no consent (n=121)
55 Declined
51 Discharged before consent 
obtained
15 Other reasons
Not assessed (n=21)
15 Discharged before assessment
6 Unable to be assessed
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Appendix Figure II. Overall calibration performance of the six-month model in the validation cohort 
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Appendix Figure III. Overall calibration performance of the 12-month model in the validation cohort 
 
 
